Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -342,601 | -269,949 | -237,734 | -129,874 | -79,413 |
| Depreciation Amortization | -6,298 | -15,115 | -10,968 | 45 | 1,085 |
| Accounts payable and accrued liabilities | 6,562 | -73 | -12,040 | 11,524 | 1,655 |
| Other Working Capital | 23,031 | 9,598 | -9,425 | 15,962 | 1,724 |
| Other Operating Activity | 42,915 | 43,220 | 85,997 | 8,505 | 20,368 |
| Operating Cash Flow | $-276,391 | $-232,319 | $-184,170 | $-93,838 | $-54,581 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -37,068 | -228,140 | -93,354 | -114,329 | -74,033 |
| PPE Investments | -495 | -511 | -898 | -797 | -259 |
| Investing Cash Flow | $-37,563 | $-228,651 | $-94,252 | $-115,126 | $-74,292 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 83,875 | N/A | 15,000 | 5,000 | N/A |
| Common Stock Issued | 366,987 | 459,678 | 146,793 | 295,754 | 116,593 |
| Other Financing Activity | -24,120 | -1,941 | 63,877 | 21,490 | 8,682 |
| Financing Cash Flow | $426,742 | $457,737 | $225,670 | $322,244 | $125,275 |
| Beginning Cash Position | 99,594 | 102,827 | 155,579 | 42,299 | 45,897 |
| End Cash Position | 212,382 | 99,594 | 102,827 | 155,579 | 42,299 |
| Net Cash Flow | $112,788 | $-3,233 | $-52,752 | $113,280 | $-3,598 |
| Free Cash Flow | |||||
| Operating Cash Flow | -276,391 | -232,319 | -184,170 | -93,838 | -54,581 |
| Capital Expenditure | -495 | -511 | -898 | -797 | -338 |
| Free Cash Flow | -276,886 | -232,830 | -185,068 | -94,635 | -54,919 |